• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

July 18, 2002

View Archived Issues

Simvastatin inhibits thrombin-induced tissue factor expression via the Rho/Rho kinase pathway

Read More

British Biotech presents development highlights over the last year

Read More

Efficacy of T-3811ME against meningitis caused by penicillin-resistant pneumococci

Read More

Procyon and Chiron extend PSP94 technology option agreement

Read More

ETX-100 granted orphan drug designation in alpha1-antitrypsin deficiency

Read More

Guilford initiates phase II trial of Aquavan in surgical patients

Read More

Phase II begins for irofulven + irinotecan in advanced gastrointestinal solid tumors

Read More

Selective adenosine A3 receptor ligand reduces IOP in monkeys

Read More

Second genomics-derived drug from HGS/GSK collaboration enters clinical testing

Read More

Mexiletine homodimers with superior analgesic profile

Read More

In vitro and in vivo pharmacology of EGIS-8332, a new neuroprotective agent

Read More

Salicylic acid analogues with IL-4-antagonist activity identified at Sunesis

Read More

Aventis presents new antiarrhythmic potassium channel blockers

Read More

Mechanism of action of cognition enhancer CGP-36742/DVD-742

Read More

Glycine-site NMDA modulators and their use claimed in Gruenenthal patent

Read More

Novel p38alpha kinase inhibitors in early development at Scios

Read More

Vita-Invest claims dual 5-HT reuptake inhibitors/5-HT1A receptor modulators

Read More

Adenosine A1 antagonists and their use in hypertension and other disorders

Read More

Novel anti-HIV agents in the Roche pipeline

Read More

Japanese partners withdraw potential RA therapeutic from development

Read More

Zonagen regains Vasomax rights, submits data from mechanistic trial

Read More

Effects of BIBN-4096BS on hemodynamic changes induced by capsaicin

Read More

Xenical label in E.U. changed to include data on overweight or obese type 2 diabetes patients

Read More

Yamanouchi licenses North American development and marketing rights to Z-338

Read More

Elitek approved in U.S.

Read More

AIT-034 and piracetam possess different profiles of activity in animal models of cognition

Read More

Mild cognitive impairment: state-of-the-art seminar

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 2, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 2, 2025.
  • Molecule illustration

    Unnatural Products joins Argenx in a $1.5B macrocyclic deal

    BioWorld
    Unnatural Products Inc. notched another collaboration by signing on with Argenx SE in a multitarget research collaboration. Unnatural Products, which is getting...
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • CMS logo and website

    CMS eyes competitive bidding for CGMs, insulin pumps

    BioWorld MedTech
    The U.S. Centers for Medicare & Medicaid Services posted the draft home health rule for calendar year 2026, which includes a proposal to subject continuous...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe